These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 7552485
21. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2. Dezzutti CS, Guenthner PC, Daniel S, Utz U, Cabrera T, Marshall JH, Bianco C, Lal RB, Cowan EP. Clin Diagn Lab Immunol; 2003 Jul; 10(4):715-7. PubMed ID: 12853410 [Abstract] [Full Text] [Related]
22. HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru. Verdonck K, González E, Henostroza G, Nabeta P, Llanos F, Cornejo H, Vanham G, Seas C, Gotuzzo E. Int J Tuberc Lung Dis; 2007 Oct; 11(10):1066-72. PubMed ID: 17945062 [Abstract] [Full Text] [Related]
23. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Lairmore MD, Jacobson S, Gracia F, De BK, Castillo L, Larreategui M, Roberts BD, Levine PH, Blattner WA, Kaplan JE. Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8840-4. PubMed ID: 2247455 [Abstract] [Full Text] [Related]
24. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis. Bailer RT, Lazo A, Harisdangkul V, Ehrlich GD, Gray LS, Whisler RL, Blakeslee JR. J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355 [Abstract] [Full Text] [Related]
25. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction. De Rossi A, Mammano F, Del Mistro A, Chieco-Bianchi L. Eur J Cancer; 1991 Dec; 27(7):835-8. PubMed ID: 1834112 [Abstract] [Full Text] [Related]
26. Human T-lymphotropic virus type II and neurological disease. Araujo A, Hall WW. Ann Neurol; 2004 Jul; 56(1):10-9. PubMed ID: 15236397 [Abstract] [Full Text] [Related]
27. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013. Xie J, Ge S, Zhang Y, Lin Y, Ni H, Zhang J, Chen C. PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656 [Abstract] [Full Text] [Related]
28. Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil. Gabbai AA, Bordin JO, Vieira-Filho JP, Kuroda A, Oliveira AS, Cruz MV, Ribeiro AA, Delaney SR, Henrard DR, Rosario J. Am J Trop Med Hyg; 1993 Dec; 49(6):664-71. PubMed ID: 8279633 [Abstract] [Full Text] [Related]
29. HTLV-I/II prevalence in different geographic locations. Vrielink H, Reesink HW. Transfus Med Rev; 2004 Jan; 18(1):46-57. PubMed ID: 14689377 [Abstract] [Full Text] [Related]
30. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I. Yao K, Hisada M, Maloney E, Yamano Y, Hanchard B, Wilks R, Rios M, Jacobson S. J Infect Dis; 2006 Feb 01; 193(3):427-37. PubMed ID: 16388491 [Abstract] [Full Text] [Related]
31. Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA. Khabbaz RF, Douglas JM, Judson FN, Spiegel RA, St Louis ME, Whittington W, Hartley TM, Lairmore M, Kaplan JE. J Infect Dis; 1990 Jul 01; 162(1):241-4. PubMed ID: 2192006 [Abstract] [Full Text] [Related]
32. Spastic paraparesis associated with human T-lymphotropic virus type I: a clinical, serological, and genomic study in Iranian-born Mashhadi Jews. Achiron A, Pinhas-Hamiel O, Doll L, Djaldetti R, Chen A, Ziv I, Avni A, Frankel G, Melamed E, Shohat B. Ann Neurol; 1993 Nov 01; 34(5):670-5. PubMed ID: 8239561 [Abstract] [Full Text] [Related]
33. Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile. Barrientos A, Lopez M, Sotomayor C, Pilleux L, Calderón S, Navarrete M, Otth C. J Med Virol; 2011 Apr 01; 83(4):745-8. PubMed ID: 21328393 [Abstract] [Full Text] [Related]
34. Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Saeidi M, Sasannejad P, Foroughipour M, Shahami S, Shoeibi A. Acta Neurol Belg; 2011 Mar 01; 111(1):41-4. PubMed ID: 21510232 [Abstract] [Full Text] [Related]
35. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant? Tamim H, Musharrafieh U, Ramia S, Almawi WY, Al-Jisr T, Ayoub T, Nabulsi-Majzoub M, Kazma H, Baz EK. Am J Infect Control; 2004 Jun 01; 32(4):220-3. PubMed ID: 15175617 [Abstract] [Full Text] [Related]
36. HTLV-1 and neurological conditions: when to suspect and when to order a diagnostic test for HTLV-1 infection? Araújo AQ, Leite AC, Lima MA, Silva MT. Arq Neuropsiquiatr; 2009 Mar 01; 67(1):132-8. PubMed ID: 19330234 [Abstract] [Full Text] [Related]
37. Associations among HTLV-I, HTLV-II, and HIV in injecting drug users in Salvador, Brazil. Andrade TM, Dourado I, Galvão-Castro B. J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun 01; 18(2):186-7. PubMed ID: 9637584 [No Abstract] [Full Text] [Related]
38. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]. Blejer JL, Saguier MC, Salamone HJ, Carreras LA. Sangre (Barc); 1995 Dec 01; 40(6):447-51. PubMed ID: 8850226 [Abstract] [Full Text] [Related]
39. [Neurologic diseases associated with the HTLV-1 virus in Panama]. Gracia F, Castillo L, de Lao SL, Archibold CA, Larreátegui M, Reeves WC, Levine P. Rev Med Panama; 1990 Sep 01; 15(3):197-203. PubMed ID: 2284449 [Abstract] [Full Text] [Related]